Trials / Completed
CompletedNCT00357097
The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome
A Multicenter 3:1-randomized Placebo-controlled Double-blind Phase IIIb Study on the Effects of Ropinirole on Mood/(Subclinical) Depression in the Therapy of Patients With Moderate to Severe Idiopathic RLS in Germany
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
Ropinirole has shown to improve mood in depressed patients as well as to improve the symptoms of Restless Legs Syndrome. Up to 40% of RLS patients suffer from mild depression, therefore it would be important for decisions no therapy to know whether a drug could improve both depressive and RLS symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropinirole |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2007-12-01
- Completion
- 2007-12-01
- First posted
- 2006-07-27
- Last updated
- 2012-06-07
- Results posted
- 2009-09-16
Locations
50 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00357097. Inclusion in this directory is not an endorsement.